All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0422-LX447 | Anti-CD73 (47F12C11) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 47F12C11 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX448 | Anti-CD73 (77B9A3) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 77B9A3 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX449 | Anti-CD73 (786G7) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 786G7 | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX450 | Anti-CD73 (7H10) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 7H10 | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX451 | Anti-CD73 (AD2) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | AD2 | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX452 | Anti-CD73 (12F9) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 12F9 | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-1022-LX323 | Anti-CD73 (X10X155) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X155 | Human | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX324 | Anti-CD73 (X10X156) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X156 | Human | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX325 | Anti-CD73 (X10X157) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X157 | Human | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX326 | Anti-CD73 (X10X158) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X158 | Human | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX327 | Anti-CD73 (X10X159) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X159 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX328 | Anti-CD73 (X10X160) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X160 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX329 | Anti-CD73 (X10X161) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X161 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX330 | Anti-CD73 (X10X162) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X162 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX331 | Anti-CD73 (X10X163) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X163 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX332 | Anti-CD73 (X10X164) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X164 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX333 | Anti-CD73 (X10X165) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X165 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX334 | Anti-CD73 (X10X166) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X166 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX335 | Anti-CD73 (X10X167) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X167 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-1022-LX336 | Anti-CD73 (X10X168) h(CD28-CD3ζ) CAR, piggyBac vector system | Human | X10X168 | Mouse | scFv-CD28-CD3ζ | piggyBac transposon | T cell | ||
XS-0823-LX24 | Anti-hCD73 (47) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 47 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION